ClinicalTrials.govpublic full text
A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease
sickle cell disease, scd, 6r-bh4, bh4, sapropterin dihydrochloride, endothelial dysfunction, nitric oxide, no, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 835872
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.